Patent · US Active

Cancer treatment by MALAT1 inhibition

US11359200B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 9, 2018
Grant dateJun 14, 2022
Priority date—
Expiry dateSep 23, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for treating cancer in a subject in need thereof are described that includes administering a therapeutically effective amount of an oligonucleotide that specifically hybridizes to MALAT1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.